GAVASSO, SABRINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.440
AS - Asia 1.007
EU - Europa 735
SA - Sud America 195
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 7.414
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.407
SG - Singapore 462
CN - Cina 263
IT - Italia 186
BR - Brasile 180
HK - Hong Kong 165
FI - Finlandia 107
DE - Germania 92
SE - Svezia 74
NL - Olanda 45
FR - Francia 42
PL - Polonia 37
GB - Regno Unito 36
IN - India 35
RU - Federazione Russa 34
VN - Vietnam 32
UA - Ucraina 30
CA - Canada 14
AT - Austria 11
IE - Irlanda 11
CI - Costa d'Avorio 6
ES - Italia 6
MX - Messico 6
SA - Arabia Saudita 6
TW - Taiwan 6
BD - Bangladesh 5
CH - Svizzera 5
ZA - Sudafrica 5
AU - Australia 4
CO - Colombia 4
IQ - Iraq 4
JP - Giappone 4
PK - Pakistan 4
RO - Romania 4
TR - Turchia 4
BE - Belgio 3
EU - Europa 3
AZ - Azerbaigian 2
CY - Cipro 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EC - Ecuador 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
PE - Perù 2
PS - Palestinian Territory 2
TN - Tunisia 2
UY - Uruguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
BY - Bielorussia 1
CL - Cile 1
CU - Cuba 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GM - Gambi 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
HU - Ungheria 1
IR - Iran 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
MA - Marocco 1
MK - Macedonia 1
ML - Mali 1
MW - Malawi 1
NA - Namibia 1
NC - Nuova Caledonia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
PY - Paraguay 1
RS - Serbia 1
SV - El Salvador 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 7.414
Salva come PNG Salva come JPEG
Città #
Fairfield 924
Woodbridge 550
Chandler 501
Ann Arbor 375
Houston 364
Ashburn 357
Seattle 357
Cambridge 320
Singapore 275
Wilmington 274
Hong Kong 165
Boardman 114
Jacksonville 105
Santa Clara 104
San Diego 94
Princeton 83
Beijing 81
Des Moines 63
Medford 54
Helsinki 53
Padova 51
Roxbury 39
Villafranca Padovana 32
Bytom 31
Dong Ket 31
Nanjing 29
Los Angeles 19
Shenyang 19
Falls Church 15
Hebei 15
Milan 15
New York 15
Chicago 12
London 12
Munich 11
São Paulo 11
Nanchang 10
Rio de Janeiro 10
Guangzhou 9
Nuremberg 9
Dublin 8
Norwalk 8
Pune 8
Turku 8
Dallas 7
Jinan 7
Montreal 7
Abidjan 6
Brooklyn 6
Kharkiv 6
Redwood City 6
Rome 6
Shanghai 6
Tianjin 6
Belo Horizonte 5
Frankfurt am Main 5
North Bergen 5
Vienna 5
Amsterdam 4
Atlanta 4
Bologna 4
Brasília 4
Buffalo 4
Codognè 4
Jiaxing 4
Ogden 4
Taipei 4
Trento 4
Washington 4
Blumenau 3
Campinas 3
Curitiba 3
De Zilk 3
Detroit 3
Falkenstein 3
Hangzhou 3
Istanbul 3
Kilburn 3
Kunming 3
Las Vegas 3
Lauterbourg 3
Mexico City 3
Ningbo 3
Padua 3
Porto Alegre 3
Salt Lake City 3
Salvador 3
Stockholm 3
Uberlândia 3
Warsaw 3
Zhengzhou 3
Acton 2
Adligenswil 2
Betim 2
Brussels 2
Cabo Frio 2
Campo Grande 2
Campos dos Goytacazes 2
Changsha 2
Chongqing 2
Totale 5.851
Salva come PNG Salva come JPEG
Nome #
Dynamics of circulating microparticles in obesity after weight loss 168
X-linked thrombophilia with a mutant factor IX (factor IX Padua). 159
In vitro and in vivo effects of the carbon monoxide-releasing molecule, CORM-3, in the xenogeneic pig-to-primate context 155
Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S 141
Does decreased fibrinolysis have a role to play in the development of non-neoplastic portal vein thrombosis in patients with hepatic cirrhosis? 138
The incidence of venous thromboembolism in carriers of antithrombin, protein C or protein S deficiency associated with the HR2 haplotype of factor V: a family cohort study 133
Platelet factor V levels in moderate to severe congenital factor V deficiency. 129
Factor IX activity/antigen ratio and the risk of first unprovoked venous thromboembolism. 129
Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis 127
Association between ABO blood group and bleeding phenotype in patients with mild rare bleeding disorders 127
Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms 126
Non-invasive risk stratification after HCV-eradication in patients with advanced chronic liver disease 126
Alterations in the coagulation profile in renal pig-to-monkey xenotransplantation 125
Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosis. 124
Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency. 123
Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events 123
Perioperative coagulation assessment of patients undergoing major elective orthopedic surgery 123
Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. 123
null 122
The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein i antibodies. A comparison with a homemade ELISA method 117
Effects of long-term administration of recombinant human protein C in xenografted primates. 117
Factor VIIa-antithrombin complexes in patients with arterial and venous thrombosis. 116
"Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds. 116
Endothelial damage of the portal vein is associated with Heparin-like effect in advanced stages of cirrhosis 114
Thrombin generation in Cushing's Syndrome: do the conventional clotting indices tell the whole truth? 112
Factor VIIa-antithrombin complexes in children with ischemic stroke. 111
Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis 110
Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo-coagulable and Hyper-coagulable Features 110
The role of antiphospholipid antibodies toward the protein C/protein S system in venous thromboembolic disease. 109
Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women 109
Evaluation of a procoagulant phospholipid functional assay as a routine test for measuring circulating microparticle activity. 108
“In vitro” correction of the severe factor V deficiency-related coagulopathy by a novel plasma-derived factor V concentrate 108
Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants 107
Genetic modulation of the FV(Leiden)/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotes. 107
Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct acting antivirals 105
Peculiar laboratory phenotype/ genotype relationship due to compound inherited protein C defects in a child with severe venous thromboembolism 104
Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variant. 103
The haemostatic system in acromegaly: a single-centre case–control study 99
Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis. 98
Thromboelastographic evaluation of coagulative profiles in pig-to-monkey kidney xenotransplantation. 98
Similar hypercoagulable state and thrombosis risk in type Iand type III protein S-deficient individuals from families with mixed type I/IIIprotein S deficiency. 97
Identification of a novel frameshift mutation causing a premature stop codon in a young Nigerian man with type I antithrombin deficiency. 96
Reference values for thromboelastometry (ROTEM®) in cynomolgus monkeys (Macaca fascicularis). 95
Thrombin generation in patients with COVID-19 with and without thromboprophylaxis 94
A protein S functional assay yields unsatisfactory results in patients with activated protein C resistance. 93
Thrombin activatable fibrinolysis inhibitor in cancer patients with and without venous thromboembolism. 93
Circulating microparticles in carriers of prothrombin G20210A mutation. 93
Differential effects of high prothrombin levels on thrombin generation depending on the cause of the hyperprothrombinemia. 92
Effect on thrombin generation of the "in vitro" addition of low-dose LMWH to plasma of healthy pregnant and nonpregnant women. 91
Partial F8 gene duplication (Factor VIII Padua) associated with high factor VIII levels and familial thrombophilia 91
Factor VIIa-antithrombin complexes plasma levels in cancer patients with and without thrombosis. 90
Local prothrombotic state in portal venous system in cirrhosis 89
Thrombosis and thrombophilia in children: a systematic review. 88
Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study 88
Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants. 87
Prothrombin fragment 1+2 and thrombin-antithrombin complex levels in patients with inherited APC resistance due to factor V Leiden mutation. 84
Endocytosis of exogenous factor V by ex-vivo differentiated megakaryocytes from patients with severe parahaemophilia 84
Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure 84
Determinants of increased thrombotic tendency in NASH cirrhosis: not there yet! 81
Long term use of oral contraceptives without thrombosis in patients with FV Leiden polymorphism: a study of 37 patients (2 homozygous and 35 heterozygous). 80
The risk of arterial thrombosis in carriers of natural coagulation inhibitors: a prospective family cohort study 79
Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19 62
Role of local endothelial alterations in the pathogenesis of portal vein thrombosis in cirrhosis 61
Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study 60
Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death 60
Reply to "Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis" 60
Profiling plasma alterations of extracellular vesicles in patients with acutely decompensated cirrhosis and bacterial infection 54
Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections 53
Severity of systemic inflammation is the main predictor of ACLF and bleeding in patients with acutely decompensated cirrhosis 52
Influence of hepatocellular carcinoma on platelet aggregation in cirrhosis 52
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study 51
More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC 51
Coagulation factor XI in cirrhosis does not predict thrombo-hemorrhagic complications and hepatic decompensation 44
Whole blood thrombin generation shows a significant hypo-coagulable state in patients with decompensated cirrhosis 37
Impaired whole blood thrombin generation is associated with procedure-related bleeding in acutely decompensated cirrhosis 33
Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome. 31
Reticulated platelets are increased and hyper-activated in patients with cirrhosis, especially those with poor outcome 29
Contact system and intrinsic pathway activation in patients with advanced pancreatic cancer: a prospective cohort study 28
Activation of the Contact System and Intrinsic Pathway in Peripheral and Portal Venous Circulations in Liver Cirrhosis 18
Totale 7.504
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.539
article - articoli 28.850
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.389
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202053 0 0 0 0 0 0 0 0 0 0 0 53
2020/20211.029 33 92 85 123 94 56 39 91 110 103 105 98
2021/20221.122 56 108 159 36 53 106 57 98 62 44 109 234
2022/2023857 168 114 49 96 139 103 5 50 85 4 39 5
2023/2024379 16 70 45 48 22 45 19 10 13 20 29 42
2024/20251.781 3 124 100 64 236 60 120 149 159 76 298 392
Totale 7.504